@article{8ca73cb736ae4c8eb75f3694223c1be7,
title = "Disease clearance in inflammatory bowel disease",
author = "Colombel, {Jean Fr{\'e}d{\'e}ric}",
note = "Funding Information: Dr Colombel has received research grants from AbbVie, Janssen Pharmaceuticals, and Takeda; received lecture payments from AbbVie, Allergan, Amgen, Ferring Pharmaceuticals, Shire, and Takeda; received consulting fees from AbbVie, Amgen, Arena Pharmaceuticals, BMS, Boehringer Ingelheim, Celgene Corporation, Eli Lilly, Ferring Pharmaceuticals, Galmed Research, Genentech, GlaxoSmithKline, Imedex, Immunic, Iterative Scopes, Janssen Pharmaceuticals, Kaleido Biosciences, Merck, Microba, Novartis, PBM Capital, Pfizer, Sanofi, Takeda, TiGenix, and Vifor; and held stock options in Intestinal Biotech Development.",
year = "2021",
month = may,
language = "English",
volume = "17",
pages = "233--235",
journal = "Gastroenterology and Hepatology",
issn = "1554-7914",
publisher = "Gastro-Hep Communications, Inc.",
number = "5",
}